Recombinant proteins for medical use: the attractions and challenges
- 31 December 1995
- journal article
- review article
- Published by Elsevier in Current Opinion in Biotechnology
- Vol. 6 (6) , 681-687
- https://doi.org/10.1016/0958-1669(95)80112-x
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Antigen-Induced Programmed T Cell Death as a New Approach to Immune TherapyClinical Immunology and Immunopathology, 1995
- New strategies for combatting sepsis: the magic bullets missed the mark…but the search continuesTrends in Biotechnology, 1995
- Effect of Aerosolized Recombinant Human DNase on Exacerbations of Respiratory Symptoms and on Pulmonary Function in Patients with Cystic FibrosisNew England Journal of Medicine, 1994
- Electrospray Ionization Mass Spectrometry of Recombinantly Engineered Antibody FragmentsAnalytical Chemistry, 1994
- Comparative study of a whole-cell pertussis vaccine and a recombinant acellular pertussis vaccineThe Journal of Pediatrics, 1994
- Cloning of a T Cell Growth Factor that Interacts with the β Chain of the Interleukin-2 ReceptorScience, 1994
- Potential role of granulocyte-macrophage colony-stimulating factor as vaccine adjuvantEuropean Journal of Clinical Microbiology & Infectious Diseases, 1994
- The use of animal models in cancer drug discovery and developmentThe International Journal of Cell Cloning, 1994
- Affinity Maturation of Human Growth Hormone by Monovalent Phage DisplayJournal of Molecular Biology, 1993
- Prolonged immunostimulatory effect of low-dose polyethylene glycol interleukin 2 in patients with human immunodeficiency virus type 1 infection.The Journal of Experimental Medicine, 1993